University of Bedfordfordshire
Bedford, Bedfordshire, MK41 9EA, United Kingdom
NCT Number: NCT04053686
The primary aim of this study is to assess the feasibility of an intervention to reduce and break up prolonged sitting time in full-time police staff. The secondary aims of this study are to assess preliminary effects on patterns of sedentary behaviour (number of breaks, number of prolonged sitting bouts, average duration of prolonged sitting bouts, and total prolonged sitting duration), additional measures of sedentary behaviour (total sitting time, standing, and stepping), cardiometabolic risk markers, physiological stress (cortisol levels), physical health (self-report and postural stability), psychological wellbeing and mood, work stress (self-reported), and work performance (job satisfaction and productivity).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bedford, Bedfordshire, MK41 9EA, United Kingdom
Prolonged sedentary behaviour is associated with a higher incidence of cardiovascular disease and type 2 diabetes. A large proportion of daily sedentary time (sitting) occurs in the workplace. On average, full time office workers spend upwards of 70% of their working day seated with the majority of this time accumulated in sitting bouts ≥ 20 minutes. A recent cross-sectional investigation into the occupational characteristics of over 5,000 British police force employees reported at least 30% identifying as having mainly office-based duties. When trying to reduce prolonged sitting in the workplace, one of the most effective strategies is the use of multi-component interventions. At the present time, sedentary workplace intervention studies in the police are limited.
The primary aim of this study is to assess the feasibility of an intervention to reduce and break up prolonged sitting time at work in full-time police staff. The secondary aims of this study are to assess preliminary effects on sedentary behaviour, cardiometabolic risk markers, physiological stress, physical health, psychological wellbeing and mood, work stress, and work performance.
This has a single-arm, pre-post study design. Participants will receive a multi-component intervention to break up and reduce prolonged sitting including: a presentation/workshop, electronic support, minor environmental modifications, organisational support, and team competition. Assessments will take place at baseline and post-intervention (week 10).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3-min breaks every half hour at work
Time frame: From recruitment (typically 4 weeks prior to baseline) up to study completion (typically 12 weeks)
Analyses of drop-out rates (%) in control and intervention group.
Time frame: At week 11
Asking participants' to qualitatively reflect on the intervention via semi-structured interview.
Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sit-stand transitions.
Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sitting time accrued in prolonged bouts (≥ 30 minutes).
Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of the average duration (minutes) of prolonged sitting bouts (≥ 30 minutes).
Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of the number of prolonged sitting bouts (≥ 30 minutes).
Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of sitting time.
Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of step count.
Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of total stepping time (in minutes).
Time frame: This measure will be assessed at baseline and 10 weeks. At each time point the accelerometer will be worn for 7 days.
Participants will wear a thigh-based accelerometer/inclinometer (ActivPAL3), which provides a well established measure of total standing time (in minutes).
Time frame: Baseline and at week 11
Changes in weight via Tanita scale.
Time frame: Baseline and at week 11
Changes in BMI will be computed by dividing participants' weight (in kilograms) by their height (in metres) squared.
Time frame: Baseline and at week 11
Changes in waist circumference will be assessed by tape measure.
Time frame: Baseline and at week 11
Changes in body fat percentage will be assessed via a bioelectric impedance spectroscopy device.
Time frame: Baseline and at week 11
Changes in body fat mass via a bioelectric impedance spectroscopy device.
Time frame: Baseline and at week 11
Changes in lean body mass via a bioelectric impedance spectroscopy device.
Time frame: Baseline and at week 11
Changes in blood pressure measured via electronic sphygmomanometer.
Time frame: Baseline and at week 11
Changes in total, high density lipoprotein (HDL), and low density lipoprotein (LDL) cholesterol measured via fasting blood tests using a Cholestech machine.
Time frame: Baseline and at week 11
Changes in triglycerides measured via fasting blood tests using a Cholestech machine.
Time frame: Baseline and at week 11
Changes in glucose levels measured via fasting blood tests using a Cholestech machine.
Time frame: Baseline and at week 11. At each time point saliva samples will be collected at 7 time points over the course of one day.
Changes in the cortisol awakening response and diurnal cortisol levels will be assessed via saliva samples (provided by chewing on a cotton swab for 60secs) collected seven times over the course of one day.
Time frame: Baseline and at week 11
The Nordic musculoskeletal questionnaire is comprised of 40 forced-choice questions pertaining to low back, neck, shoulder and general physical complaints most often experienced in the work setting. A visual diagram aids the viewer by labelling the nine regions of the body referred to in the questionnaire. Acceptable reliability for this tool has been demonstrated.
Time frame: Baseline and at week 11
Change in postural sway velocity (bipedal-eyes-open, bipedal-eyes-closed, unipedal-eyes-open, unipedal-eyes-closed) will be evaluated via dynamic plantar pressure sensor (RS Footscan).
Time frame: Baseline and at week 11
Change in postural sway range (bipedal-eyes-open, bipedal-eyes-closed, unipedal-eyes-open, unipedal-eyes-closed) will be evaluated via dynamic plantar pressure sensor (RS Footscan).
Time frame: Baseline and at week 11
Changes in self-reported physical activity and total sitting time. The International Physical Activity Questionnaire short form (IPAQ) measures self-reported physical activity and sitting time in the last seven days. Participants are asked to report frequency of participation (0-7 days) and duration of activity on one of those days (in hours and minutes). The IPAQ has demonstrated acceptable reliability and validity in measuring activity in the last seven days.
Time frame: Baseline and at week 11
The Marshall sitting questionnaire has five questions that measure self-reported domain-specific sitting time (hours and minutes) on weekend days and weekdays. This questionnaire has good reliability and validity for sitting time on weekdays and weekend days.
Time frame: Baseline and at week 11
The Warwick-Edinburgh mental well-being scale (WEMWBS) is a 14-item questionnaire used to assess various aspects of positive mental health (e.g., "I've been feeling optimistic about the future"). Participants are asked to rate their experience of each wellbeing statement between 1 and 5 (1 = none of the time and 5 = all of the time). Item scores are then combined to provide a total score (between 14 - 70). The higher the score the better the overall mental wellbeing. For intervention purposes, a change in the total score of 3-8 points between two time points may be considered a "meaningful change".
Time frame: Baseline and at week 11
Changes in self-reported mood via the positive and negative affect schedule (PANAS) consisting of two 10-item subscales to measure positive and negative affect (i.e., mood). A number of words that describe different feelings and emotions (e.g., "interested", "distressed", "excited") are presented and participants are asked to indicate on a 5-point scale to what extent over the past week they have felt these feelings/emotions (1 = very slightly or not at all and 5 = extremely). These scales are internally consistent with very good convergent and discriminant correlations.
Negative Affect subscale Item scores on the negative affect scale are then combined to provide a total score (between 10 - 50). The higher the score the more negative emotions experienced.
Positive Affect subscale Item scores on the positive affect scale are then combined to provide a total score (between 10 - 50). The higher the score the more positive emotions experienced.
Time frame: Baseline and at week 11
Changes in ratings of 20 operational stressors for police (PSQ-Org). Participants will be asked to rate items on "how much stress it has caused you over the past 6 months" using a 7-point Likert scale (1 = no stress at all and 7 = a lot of stress). Item scores are then combined to provide a total score (between 20 - 140). The higher the score the worse the stress level. This instrument has demonstrated acceptable reliability and validity for measuring police-specific occupational stressors.
Time frame: Baseline and at week 11
Changes in ratings of 20 organisational stressors for police (PSQ-Org). Participants will be asked to rate items on "how much stress it has caused you over the past 6 months" using a 7-point Likert scale (1 = no stress at all and 7 = a lot of stress). Item scores are then combined to provide a total score (between 20 - 140). The higher the score the worse the stress level. This instrument has demonstrated acceptable reliability and validity for measuring police-specific occupational stressors.
Time frame: Baseline and at week 11
Changes in self-reported job satisfaction and will be evaluated via a single-item questionnaire ("How satisfied are you with your job in general?") assessed on a 7-point Likert scale (1 = dissatisfied and 7 = extremely satisfied). A higher score represents more satisfaction with one's job.
Time frame: Baseline and at week 11
Changes in self-reported job performance will be evaluated via a single-item questionnaire ("How well do you think you have performed in your job recently?") with a 7-point Likert scale (1 = very poorly and 7 = extremely well). A higher score represents a more positive assessment of job performance.
University of Bedfordshire
Other
A-REST (Activity to Reduce Excessive Sitting Time): a Cluster Randomised Controlled Feasibility Trial to Reduce Prolonged Sitting in Police Staff
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07665333
Behavior, Behavior, Animal
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05585190
Behavior, Body Weight
Milwaukee, Wisconsin, United States
View Trial DetailsNCT06377254
Age-Related Sarcopenia, Age-related Cognitive Decline
Nottingham, Notts, United Kingdom
View Trial DetailsNCT04207333
Behavior, Behavioral Symptoms
Chapel Hill, North Carolina, United States
View Trial Details